Respiratory Tract Diseases  >>  Soliris (eculizumab)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Soliris (eculizumab) / AstraZeneca
NCT00485576: Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma

Completed
2
21
Canada
eculizumab
Alexion Pharmaceuticals
Allergic Asthma
09/08
11/08

Download Options